GE HealthCare Technologies Inc.

NASDAQ:GEHC

Medical - Healthcare Information Services

Healthcare
$83.66 +0.74%

+$0.45 today

Market cap
$37.83B
Beta
0.86
P/E (TTM)
18.7
EPS (TTM)
$3.30
Dividend yield
0.23%
52W Low $58.75High $89.77

Volume 3.65M

Average 4.84M

GEHC Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

GE HealthCare Technologies Inc.NASDAQ: GEHC

Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026

Capital expenditures grows, but more slowly than its trailing trend

Q2 FY2026 capital expenditures of $100M (cash outflow) rose 16.3% year over year, behind the +21.4% change in trailing-twelve-month capital expenditures. Sequentially, it fell 43.8% from the prior quarter. Over 3 fiscal years it compounded at +15.8% a year.

Context

  • Capital expenditures amounted to 2.3% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Capital expenditures grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +16.3% toward the trailing-twelve-month pace of +21.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$100M-43.8% QoQ
Last fiscal yearDec 2025
-$482M+20.2% YoY
LTMJun 2026
-$522M+21.4% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.3%——
1 year+20.2%——
3-year CAGR+15.8%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(482M) USD
Year-over-year change
-20.2%

Capital Expenditures vs competitors

How GEHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +21.4% is the 2nd highest of 6, against a peer median of +3.3%.
  • Capital expenditures amounts to 2.6% of revenue for GEHC, versus a peer median of 3.2%.
GEHC Competitors
Capital Expenditures for GEHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$1.9B USD+3.3%+9.3%5.1%
ABTAbbott LaboratoriesLTM Jun 2026$1.19B USD-47.6%+6.9%2.5%
BSXBoston Scientific CorporationLTM Jun 2026$904M USD-7.2%+12.7%4.3%
SYKStryker CorporationLTM Jun 2026$823M USD+10.9%+9.0%3.2%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$522M USD+21.4%+15.8%2.6%
PHGKoninklijke Philips N.V.LTM Jun 2026€382.2M EUR+76.2%-16.8%2.2%
Peer median (excluding GEHC) —+3.3%+9.0%3.2%

Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.28B1.95B1.62B2.05B2.15B
Depreciation & Amortization625M633M610M580M578M
Deferred Income Tax600M563M743M531M0
Stock-Based Compensation76M67M114M125M130M
Change in Working Capital(1.37B)(293M)22M(59M)(357M)
Accounts Receivables(1.16B)(440M)(171M)(150M)(216M)
Inventory(435M)(402M)111M(81M)(142M)
Accounts Payables263M481M(13M)126M90M
Other Working Capital(42M)68M95M46M(89M)
Other Non-Cash Items(599M)(806M)(1.01B)(1.28B)(517M)
Operating Cash Flow1.61B2.11B2.1B1.95B1.99B
Capital Expenditures(248M)(310M)(387M)(401M)(482M)
Acquisitions (Net)(1.48B)0(147M)(313M)0
Purchases of Investments0(59M)(48M)(40M)(118M)
Sales of Investments00000
Other Investing Activities(32M)(29M)24M(160M)(447M)
Investing Cash Flow(1.76B)(398M)(558M)(914M)(1.05B)
Debt Repayment(12M)8.2B1.14B(423M)967M
Common Stock Issued00033M37M
Common Stock Repurchased0000(200M)
Dividends Paid00(41M)(55M)(64M)
Other Financing Activities(251M)(9.03B)(1.58B)(128M)(123M)
Financing Cash Flow(263M)(822M)(478M)(573M)617M
Effect of Forex Changes(34M)(3M)(10M)(77M)64M
Net Change in Cash(451M)890M1.06B387M1.62B
Free Cash Flow1.36B1.8B1.71B1.55B1.51B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Intrinsic Alpha fair value

Locked

Current Price

$83.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.